Main menu

Spanish-language webinar: Integrating Nanopore Sequencing Into Clinical Research - Case Studies in Pathogen, Cancer and Genomics Analysis


Long-read sequencing provides advantages over short reads for a multitude of applications including characterising pathogens, analysing cancer genomic alterations and accurately detecting structural variants in the human genome.

In this webinar, Dr. Alfredo Hidalgo Miranda demonstrates the potential and flexibility of Oxford Nanopore Technologies’ sequencing platforms in cancer and infectious disease research. He showcases the use of the Oxford Nanopore sequencing platform to sequence SARS-CoV-2 and Mycobacterium tuberculosis to monitor viral evolution and drug resistance. Dr. Hidalgo Miranda also highlights the transcriptomic analysis, characterisation of chromosomal translocations and the identification of mutations with diagnostic potential in lymphoblastic leukemia samples.

Authors: Alfredo Hidalgo Miranda, PhD Principal Investigator at Instituto Nacional de Medicina Genomica Dr. Alfredo Hidalgo Miranda is a Biologist and a PhD in Biomedical research. His current work at the Cancer Genomics laboratory of the Mexican National Institute of Genomic Medicine, is focused on the analysis of genomic and transcriptomic alterations in human tumours, particularly breast cancer. He has recently incorporated long-read sequencing analysis to improve the characterisation of genomic diversity in the Mexican population and the analysis of cancer and rare diseases.

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag